🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi

EntrackrEntrackr · 9d ago
Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi
Medial

Precision oncology startup 4baseCare has raised Rs 90 crore ($9.8 million) in the first close of its Series B round co-led by Ashish Kacholia and Lashit Sanghvi, with participation from existing investor Yali Capital. The new round comes after a gap of two years. In 2024, the company had raised $6 million in Series A funding, led by Yali Capital, with participation from Infosys. The fresh capital will be used to expand 4baseCare’s hospital-linked genomics lab network across India, the Middle East, Southeast Asia, Latin America, and Central Asia. It will also scale its AI-powered precision oncology platform, OncoTwin, which supports clinical decision-making for cancer treatment. Founded by Hitesh Goswami, 4baseCare focuses on building population-relevant clinico-genomic datasets to improve cancer diagnosis and treatment outcomes in underrepresented populations. Its platform integrates genomic testing with real-world clinical and outcomes data to generate actionable insights for oncologists. The OncoTwin platform was recently selected for the MSK iHub program at Memorial Sloan Kettering Cancer Center, New York. The company works closely with hospitals to offer genomics-led cancer diagnostics within clinical settings and is positioning itself to scale across emerging markets. Investor interest in cancer-focused startups has picked up in recent years. Last year, Everhope Oncology raised $10 million in seed funding, and MOC Cancer Care & Research Centre secured $18 million led by Elevation Capital. ErlySign, OnCare, and OneCell Diagnostics are also among the funded startups.

Oncare bags $1 Mn in seed round led by Huddle Ventures

EntrackrEntrackr · 1y ago
Oncare bags $1 Mn in seed round led by Huddle Ventures
Medial

Oncare, a cancer care startup, has raised $1 million in its seed round led by Huddle Ventures. The round also saw participation from marquee institutional VCs such as TRTL Ventures, Cloud Capital, and DeVC. The proceeds will be used to expand its operations to 10 new centres across Delhi NCR, Bangalore, and Jaipur over the next two years. The funds will also be channelled towards team expansion and marketing efforts to raise awareness about the brand’s affordable cancer care solutions. Founded in 2023 by Deepak Kumar and Amar Sneh, Oncare is partnering with 50-100 bedded hospitals to create dedicated oncology wings. Through these partnerships, Oncare is reducing treatment costs by up to 40%. The brand claims to offer an affordable yet high-quality alternative to the expensive cancer treatment—often exceeding Rs 10 lakh in corporate hospitals. It also offers on-call nursing support to help patients manage side effects and anxiety associated with cancer therapies, without having to make unnecessary hospital visits. The startup is operational in South Delhi for the past 10 months and it has provided over 2,500 patients with guidance on treatment plans and claims to have completed over 500 treatment sessions. According to the annual Health of Nation report by Apollo Hospitals, the cancer burden in India is staggering, with yearly cases expected to rise from 1.39 million in 2020 to 1.57 million by 2025. However, high treatment costs, limited availability of oncology centres, and a shortage of specialised professionals are making cancer care inaccessible to millions.

Binny Bansal-backed RISA Labs raises $11.1 Mn in funding

EntrackrEntrackr · 22d ago
Binny Bansal-backed RISA Labs raises $11.1 Mn in funding
Medial

RISA Labs, an AI-driven healthtech startup, has raised $11.1 million in a funding round co-led by Cencora Ventures and Optum Ventures. The round also saw participation from Oncology Ventures, Z21 Ventures, and John Simon of Ventureforgood, along with existing backer Binny Bansal, co-founder of Flipkart. Earlier in April last year, RISA Labs had raised $3.5 million in a seed funding round led by Flipkart co-founder Binny Bansal and others. The proceeds will be used to scale product development, expand deployments with hospitals and cancer care networks, and support customer onboarding across the US healthcare system. Founded in the US, RISA Labs is building an AI operating system for cancer care. The platform focuses on automating clinical and administrative workflows in oncology, helping healthcare providers reduce manual effort, improve coordination, and speed up treatment processes. RISA Labs is targeting oncology providers that deal with complex workflows involving diagnostics, treatment planning, approvals, and patient coordination.

Truva, 4baseCare, two others secure early-stage funds

VCCircleVCCircle · 1y ago
Truva, 4baseCare, two others secure early-stage funds
Medial

On Monday, early-stage funds were secured by several startups including 4baseCare, Infinyte.Club, Truva, HealthCRED, and Haldèn. 4baseCare, an oncology solutions startup, raised $6 million in a Series A funding round to enhance its product offerings and scale up operations across Asia. Infinyte.Club, a wealth management platform, raised $3.6 million in a seed round to provide its members access to private company stocks. Truva, a real estate technology platform, secured $3 million to expand its team, enhance products, and raise debt for working capital. HealthCRED, a healthcare financing startup, raised undisclosed funds to address the working capital gap in hospitals. Haldèn, a luxury men's brand, raised Rs 5 crore to expand its product range.

4baseCare raises $6 Mn in Series A round led by Yali Capital

EntrackrEntrackr · 1y ago
4baseCare raises $6 Mn in Series A round led by Yali Capital
Medial

Healthcare startup 4baseCare has raised $6 million in its Series A round led by Yali Capital. As per the company, the proceeds will be used to enhance product offerings and scaling up operations for further expansion across India, as well as other countries in Asia and the Middle East. Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare’s offers precision oncology solutions using advanced genomics and digital health technology. Its genomic tests have made a substantial impact across SouthEast Asia, impacting over 10,000 cancer patients. Its genomic-based tests include Indiegene which it claims is the world’s first Indian population specific cancer gene panel for biomarker testing. Over the next few months, 4baseCare will set up genomics laboratories in the Philippines, Nepal, and Dubai. Additionally, it will focus on building genomics and digital health solutions, focusing on advanced data analytics, improved clinical insights, and data-driven treatment recommendations.

Download the medial app to read full posts, comements and news.